Close
This is
an open seminar series organised to highlight some of the very best academic
and industrial research in applied drug discovery. All speakers have been
invited to present an overview of their particular research areas.
Organiser: Prof Stephen Neidle
- 4th March 2015, Room JHLT, 2:30 pm - Dr Mark Sanderson, King's College London. Bacterial type II topoisomerases, structure, mechanism and drug inhibition.
- 15th Jan 2015, Room JHLT, 2:30 pm - Dr Clive McCarthy, Evotec. Kinase inhibiton: still life in the old dog?
- Nov 26th 2014, Room JHLT, 2:30pm - Prof Chris Schofield, University of Oxford UK. The chemistry of oxygen sensing in humans and other animals.
- Oct 29th 2014, Room JHLT, 4:00 pm - Dr Tim Somervaille, Cancer Research UK Manchester Institute. LSD for AML? Therapeutic targeting of epigenetic modifiers in haematological malignancies.
- Oct 15th 2014, Room JHLT, 2:30pm - Dr David Rees, Senior VP, Medicinal Chemistry, Astex UK. Fragment-based drug discovery for PPI's: novel inhibitors of IAP.
- Sept 17th 2014, Room JHLT, 2:30pm - Prof Stephen Neidle, UCL School of Pharmacy UK. Progress in targeting pancreatic cancer at the gene level.
- July 9th 2014, Room JHLT, 2:30pm - Professor Julian Blagg, The Institute of Cancer Research UK. Structure-based design of orally bioavailable MPS1 inhibitors.
- May 22nd 2014, Room 225, 1:00pm – Dr Magnus Walter, Head of Chemistry, Eli Lilly UK. Challenges in CNS Drug Discovery - A Case Study. Novel mGlu5 antagonists for the Treatment of Parkinson's Disease.
- May 20th 2014, Room M1, 11:00am – Dr Hitesh Sanganee, Strategic Partnering & Alliances, AstraZeneca UK. Open Innovation platform - New opportunities for collaborations.
- March 5th 2014, Room JHLT, 2:30pm - Dr Matthew Fuchter, Imperial College London UK. Small molecule epigenetic intervention of disease.
- January 15th 2014, Room JHLT, 2:30pm - Professor Chris Abell, University of Cambridge UK. Fragment based approaches in chemical biology and drug discovery.
- January 15th 2014, Room 225, 12:00pm - Prof Adrian Elcock, University of Iowa, USA. Use of molecular simulations to model large-scale biomolecular systems.
Contact: Prof Stephen Neidle